Pan Cancer (private company)
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth servicesPharma
Business model:B2B
Pan Cancer is a Dutch biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies.
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 12.06M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Pan Cancer
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
67%
|
|
![]() |
Acesion Pharma
67%
|
|
![]() |
Cinclus Pharma
67%
|
|
![]() |
NMD Pharma
67%
|
|
![]() |
ReViral
67%
|
|
![]() |
Sanifit Therapeutics
67%
|
|
![]() |
STipe Therapeutics
67%
|
|
![]() |
Synklino
67%
|
|
![]() |
Theolytics
67%
|
|
![]() |
Cytoki Pharma
67%
|
|